Furumoto et al (27) reported that high RECK expression correlates with less invasive tumors and an improved prognosis in patients with hepatocellular carcinoma, and that downregulated RECK expression could induce tumor angiogenesis and promote tumor regression. Here, RECK is linked to neoplasm.